Induced sputum markers of fibrosis and decline in pulmonary function in asbestosis and silicosis: A pilot study

International Journal of Tuberculosis and Lung Disease

Volumn 12, Issue 7, 2008, Pages 813-819

  Prince, P ^a   Boulay, M E ^a   Page, N ^a   Desmeules, M ^a   Boulet, Louis Philippe ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Mediators of inflammation; Occupational lung diseases; Pneumoconiosis

Indexed keywords

CYTOKINE; FIBRONECTIN; GELATINASE B; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; ASBESTOSIS; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; EOSINOPHIL; FORCED EXPIRATORY VOLUME; HUMAN; INFLAMMATORY CELL; LUNG FIBROSIS; LUNG FUNCTION; LUNG FUNCTION TEST; MALE; MEDIATOR RELEASE; NEUTROPHIL; OCCUPATIONAL EXPOSURE; PILOT STUDY; PRIORITY JOURNAL; SILICOSIS; SPUTUM ANALYSIS; TOTAL LUNG CAPACITY;

AGED; ASBESTOSIS; BIOLOGICAL MARKERS; HUMANS; INTERLEUKIN-1BETA; MALE; MIDDLE AGED; PILOT PROJECTS; PULMONARY FIBROSIS; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; SILICOSIS; SPUTUM;

EID: 47149101303     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Silicosis and Silicate Disease Committee. Diseases associated with exposure to silica and nonfibrous silicate minerals. Arch Pathol Lab Med 1988; 112: 673-720.
2. Ziskind M, Jones R N, Weill H. Silicosis. Am Rev Respir Dis 1976; 113: 643-665.
3. Weill H, Jones R N, Parkes W R. Silicosis and related diseases. In: Parkes WR, ed. Occupational lung disorders. 3rd ed. London, UK: Butterworth Heinemann, 1994.
4. Vanhee D, Gosset P, Boitelle A, Wallaert B, Tonnel A B. Cytokines and cytokine network in silicosis and coal workers' pneumoconiosis. Eur Respir J 1995; 8: 834-842.
5. Vallyathan V, Goins M, Lapp L N, et al. Changes in broncho-alveolar lavage indices associated with radiographic classification in coal miners. Am J Respir Crit Care Med 2000; 162: 958-965.
6. Geliert A R, Langford J A, Winter R J, et al. Asbestosis: assessment by bronchoalveolar lavage and measurement of pulmonary epithelial permeability. Thorax 1985; 40: 508-514.
7. Cullen M R, Merrill W W. Association between neutrophil concentration in bronchoalveolar lavage fluid and recent losses in diffusing capacity in men formerly exposed to asbestos. Chest 1992; 102: 682-687.
8. Pizzichini E, Pizzichini MMM, Efthimiadis A, et al. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med 1996; 154: 308-317.
9. Pin I, Gibson P G, Kolendowicz R. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 1992; 47: 25-29.
10. Spanevello A, Migliori G B, Sharara A, et al. Induced sputum to assess airway inflammation: a study of reproducibility. Clin Exp Allergy 1997; 27: 1138-1144.
11. Spanevello A, Confalonieri M, Sulotto F, et al. Induced sputum cellularity. Reference values and distribution in normal volunteers. Am J Respir Crit Care Med 2000; 162: 1172-1174.
12. Wilson N M, Bridge P, Spanevello A, Silverman M. Induced sputum in children: feasibility, repeatability, and relation of findings to asthma severity. Thorax 2000; 55: 768-774.
13. Teschler H, Thompson A B, Dollenkamp R, Konietzko N, Costabel U. Relevance of asbestos bodies in sputum. Eur Respir J 1996; 9: 680-686.
14. Fireman E, Greif J, Schwarz Y, et al. Assessment of hazardous dust exposure by BAL and induced sputum. Chest 1999; 115: 1720-1728.
15. Miller M R, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005; 26: 319-338.
16. Knudson R J, Lebowitz M D, Holberg C J, Burrows B. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis 1983; 127: 725-734.
17. St-Laurent J, Boulay M E, Prince P, Bissonnette E, Boulet L P. Comparison of cell fixation methods of induced sputum specimens: an immunocytochemical analysis. J Immunol Methods 2006; 308: 36-42.
18. Begin R, Martel M, Desmarais Y. Fibronectin and procollagen 3 levels in bronchoalveolar lavage of asbestos-exposed human subjects and sheep. Chest 1986; 89: 237-243.
19. Srivastava K D, Rom W N, Jagirdar J, et al. Crucial role of interleukin-1beta and nitric oxide synthase in silica-induced inflammation and apoptosis in mice. Am J Respir Crit Care Med 2002; 165: 527-533.
20. Zhang Y, Lee T C, Guillemin B, Yu M C, Rom W N. Enhanced IL-1 beta and tumor necrosis factor-alpha release and messenger RNA expression in macrophages from idiopathic pulmonary fibrosis or after asbestos exposure. J Immunol 1993; 150: 4188-4196.
21. Kline J N, Schwartz D A, Monick M M, Floerchinger C S, Hunninghake G W. Relative release of interleukin-1 beta and interleukin-1 receptor antagonist by alveolar macrophages. A study in asbestos-induced lung disease, sarcoidosis, and idiopathic pulmonary fibrosis. Chest 1993; 104: 47-53.
22. Davis G S, Pfeiffer L M, Hemenway D R. Persistent overexpression of interleukin-1beta and tumor necrosis factor-alpha in murine silicosis. J Environ Pathol Toxicol Oncol 1998; 17: 99-114.
23. Piguet P F, Collart M A, Grau G E, Sappino A P, Vassalli P. Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosis. Nature 1990; 344: 245-247.
24. Gossart S, Cambon C, Orfila C, et al. Reactive oxygen intermediates as regulators of TNF-alpha production in rat lung inflammation induced by silica. J Immunol 1996; 156: 1540-1548.
25. Lindroos P M, Coin P G, Badgett A, Morgan D L, Bonner J C. Alveolar macrophages stimulated with titanium dioxide, chrysotile asbestos, and residual oil fly ash upregulate the PDGF receptor-alpha on lung fibroblasts through an IL-1beta-dependent mechanism. Am J Respir Cell Mol Biol 1997; 16: 283-292.
26. Raines E W, Dower S K, Ross R. Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA. Science 1989; 243: 393-396.